Product photo · 10mg
Reports describe submitted samples for this amount and form.
Cagrilintide
An experimental long-acting drug being studied for appetite and body weight.
What does the amount mean?
10 mg is an amount of material. Read the label to see whether it means per vial, per tablet, or per package.
Read more1 vial · 10mg in each vial
You can add this product to your cart. Checkout is temporarily unavailable.
Lab resultsCagrilintide, explained
An experimental long-acting drug being studied for appetite and body weight.
What it’s used for
Trial formulations
Research distinguishes cagrilintide alone from the CagriSema combination.
Metabolic research
Appetite and blood-sugar outcomes are also studied.
- Research interests
- Weight loss · Appetite · Fullness
Human weight-management trials show promise; exact treatment context matters.
What to expect
- Weeks 1–2
Body adjusts; stomach side effects are common
- Weeks 4–8
2–5% weight loss
- Weeks 12–26
10–15% weight loss
- Week 26+
15–23% weight loss
Side effects & safety
Side effects
- Nausea, vomiting and diarrhea
- Stomach and gut side effects hit 41–63% of people on cagrilintide alone, versus 32% on placebo
- Injection-site reactions
- With semaglutide in type 2 diabetes, gut side effects affected 72.5% versus 34.4% on placebo
Stop and get help if
- Unable to stay hydrated
- Severe stomach pain that spreads to the back
- Signs of an allergic reaction
- An abscess at the injection site
- The solution looks cloudy, has particles or turns gel-like — discard it
Avoid or check first
- Taking pramlintide — it doubles up on the same amylin activity
- Taking insulin — blood sugar and meal-timing effects need close monitoring
In sport
- The reference reports: likely banned at all times.
How much people usually take
Weight loss (monotherapy)
Once weekly · injectable
Weight loss (CagriSema)
Once weekly · injectable
Combination diabetes therapy
Once weekly · injectable
How to mix and store it
How many units do I draw?
How to mix5 steps
Wipe both tops
Wash your hands, then swab both rubber vial tops with alcohol. Let them dry.
Draw the water
Use a new sterile syringe to draw the water volume selected in the calculator.
Run it down the wall
Introduce the water slowly down the inside glass wall, rather than directly onto the powder.
Swirl, don’t shake
Gently swirl or roll the vial. Allow time for the powder to dissolve.
Label the vial
Write the preparation date and the amount and final volume on the vial label.
Injecting under the skinWhere, rotating sites, which syringe
Where
Subcutaneous injections go into the fatty layer beneath the skin. Common sites include the abdomen, outer thigh and upper arm. Keep at least 5 cm from the navel and avoid bruised, irritated or damaged skin.
Rotate sites
Change the spot each time. Clean the skin and let it dry.
Single-use equipment
Use a new sterile needle and syringe each time. Place used needles in a sharps container.
Storage
Storage
Refrigerated at 2–8°C.
Combining it with others
Don’t combine
- Eloralintide
Both affect the amylin appetite hormone, which may add to nausea.
Use caution
- Tirzepatide
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Retatrutide
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Survodutide
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Mazdutide
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Orforglipron
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Tesofensine
Concerns about heart rate, blood pressure and eating too little may add up.
Other combinations
Often taken together
- Semaglutide
CagriSema studies do not show that separately mixed products are compatible.
What the research says
Amylin and calcitonin receptors
Lab research examined how long-acting cagrilintide binds to the hormone signals amylin and calcitonin.
Combination research
An early human trial studied cagrilintide with semaglutide, combining effects on the appetite hormones amylin and GLP-1.
What it’s made of
Lab results
10mg · 1 linked report
- Purity · sample result
- 99.666% / 99.617% / 99.693%
- Amount found · Cagrilintide
- Sample 1: 10.6 mgSample 2: 10.1 mgSample 3: 10.15 mg
Separate sample results, in report order.
Purity & amount
Sample batch CAG02
These are submitted-sample results, separate from general research or popularity ratings. Report presentation: Peptify Analytics. Source laboratory: Janoshik Analytical. The connection to the batch you would receive is not confirmed here.
Videos worth watching
Research conversations, with their original context.
Video resources are not available for this guide.
Read the original sourcesProduct details
- Form
- Vial
- Amount
- 10mg
Sources & further reading
Follow each reference to its original publication or documentation.
- Primary research · 2021Cagrilintide plus semaglutide phase 1b PK and safety trial (opens in a new tab)
- Reference reportPepSavvy: Cagrilintide (opens in a new tab)
- Official documentationCDC: Preventing Unsafe Injection Practices (opens in a new tab)
- Official documentationMedlinePlus: Subcutaneous injections (opens in a new tab)
Questions
What does 10mg mean?
It describes an amount of material in the unit stated on the label. It does not describe liquid volume, a dose, or how to prepare the product.
Read more about amountsDoes purity mean it is sterile?
No. Purity and sterility require different tests. An endotoxin result also does not establish sterility.
About testingCan I calculate concentration?
You need a mass in mg and either a final volume or a target concentration. IU and blends require separate, verified information.
Use the mixing helper for this amount ↑How can I get help with an order?
Open your order details to check its current status. Shipping and support information are available below.
Contact usMore to explore
Shop allHGH – Batch GGC41 110iu Kit
HGH Batch GGC41 is the 110iu kit listing for human growth hormone, studied for the cell-signaling pathways connecting growth hormone receptors to metabolic responses.
Single Peptides
110iu / kit
HGH – Batch GGC40 430iu Kit
HGH Batch GGC40 is the 430iu kit listing for human growth hormone, a protein hormone at the center of growth hormone receptor and metabolic-signaling research.
Single Peptides
430iu / kit
HGH – Batch GGC39 420iu Kit
HGH Batch GGC39 is the 420iu kit listing for human growth hormone, with research centered on receptor signaling, gene activity and the growth hormone–IGF-1 pathway.
Single Peptides
420iu / kit
HGH – Batch GGC38 280iu Kit
HGH Batch GGC38 is the 280iu kit listing for human growth hormone, a protein hormone studied for growth hormone receptor signaling and downstream IGF-1 biology.
Single Peptides
280iu / kit